Glycine Irrigant label

Glycine Irrigant

Glycine Irrigant Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Solutions for urologic irrigation must be used with caution in patients with severe cardiopulmonary or renal dysfunction.

The amount of fluid absorbed during a transurethral resection is a function of the volume and hydrostatic pressure of the irrigant used, the number and size of venous sinuses opened, and the duration of the procedure. Since irrigating fluids used during transurethral prostatectomy have been demonstrated to enter the systemic circulation in relatively large volumes, any irrigation solution must be regarded as a systemic drug.

Absorption of large amounts of fluids containing glycine and the resultant osmotic diuresis may significantly affect cardiopulmonary and renal dynamics. Absorption of large amounts of irrigating solution can also result in pronounced hyponatremia and water intoxication.

After opening container, the contents should be used promptly to minimize the possibility of bacterial growth or pyrogen formation.

Discard unused portion of irrigating solution since it contains no preservative.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

1.5% Glycine Irrigation USP is indicated as an irrigant during transurethral prostatic or bladder surgery.

History

There is currently no drug history available for this drug.

Other Information

Each 100 mL contains:

Glycine USP …………………………………………………………………………. 1.5 g
Water for Injection USP ………………………………………………………….     qs

pH: 6.1 (4.5-6.5)
Calculated Osmolarity: 200 mOsmol/liter

The formula of the active ingredient is:

Ingredient Molecular Formula Molecular Weight
 Glycine USP  NH2CH2COOH  75.07

1.5% Glycine Irrigation USP is a sterile, nonpyrogenic aqueous solution suitable for urologic irrigation. This solution is slightly hypotonic.

The plastic container is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. The copolymer contains no plasticizers and exhibits virtually no leachability. The plastic container is also virtually impermeable to vapor transmission and therefore, requires no overwrap to maintain the proper drug concentration. The safety of the plastic container has been confirmed by biological evaluation procedures. The material passes Class Vl testing as specified in the U.S. Pharmacopeia for Biological Tests – Plastic Containers. These tests have shown that the container is nontoxic and biologically inert.

The PIC™ Container is PVC-free and DEHP-free.

Glycine Irrigant Manufacturers

  • B. Braun Medical Inc.
    Glycine Irrigant | B. Braun Medical Inc.
    No Recall

    Glycine Irrigant | B. Braun Medical Inc.

    Glycine Irrigant | B. Braun Medical Inc.

    As required for irrigation.

    1.5% Glycine Irrigation USP should be administered only by the appropriate transurethraI urologic instrumentation.

    It has been reported that absorption is significantly increased if the container is higher than 60 cm (24") above the patient.

    This drug product should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

  • Glycine Irrigant | Hospira, Inc.
    No Recall

    Glycine Irrigant | Hospira, Inc.

    Glycine Irrigant | Hospira, Inc.

    1.5% Glycine Irrigation, USP should be administered only by transurethral instillation with appropriate urologic instrumentation. A disposable irrigation set should be used. The total volume of solution used for irrigation is solely at the discretion of the surgeon.

    Height of container(s) above the operating table in excess of 60 cm (approx. 2 ft.) has been reported to increase intravascular absorption of the irrigating fluid.

    Drug Interactions

    Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.

    Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits. See PRECAUTIONS.

  • B. Braun Medical Inc.
    Glycine Irrigant | B. Braun Medical Inc.
    No Recall

    Glycine Irrigant | B. Braun Medical Inc.

    Glycine Irrigant | B. Braun Medical Inc.

    As required for irrigation.

    1.5% Glycine Irrigation USP should be administered only by the appropriate transurethraI urologic instrumentation.

    It has been reported that absorption is significantly increased if the container is higher than 60 cm (24") above the patient.

    This drug product should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.